ROYAL BANK of CANADA

RBC’s latest U.S. equity research notes upgrade Medline Corp to “moderate buy” and give Phreesia Inc. an “outperform” rating, spotlighting growth in healthcare supply and digital health tech.

RBC’s latest moves—Tesla buy‑ups, quantum‑tech funding and a housing‑market spin—hide hidden conflicts, opaque disclosures and real‑world risks. Discover why regulators, investors and consumers need sharper scrutiny.

RBC’s new prospectus and BMO’s 10% price‑target lift underscore solid growth and robust capital, making the bank a compelling buy for income and growth investors.

RBC’s solid, diversified platform and moderate valuation make it a steady choice for long‑term investors, even as it drives digital wealth, green finance and cross‑border M&A opportunities.

Royal Bank of Canada’s Q3 2025 financials have led to a significant surge in its stock price, driven by record-breaking net income and diversified growth across its financial services and global operations.

Royal Bank of Canada’s stock price remains stable, with a slight increase, while the company introduces a new initiative to support Indigenous Peoples through a no-fee bank account.

Royal Bank of Canada has introduced a no-monthly-fee bank account for Indigenous clients and increased its stake in Bitcoin proxy MicroStrategy, marking a significant step forward in its efforts to reconcile with Indigenous Peoples and innovate in t…

Royal Bank of Canada has issued a high-coupon bond to bolster its financial reserves and fuel its growth trajectory, sparking interest among investors and analysts.

Royal Bank of Canada is set to release its third-quarter results on August 27, providing investors with valuable insights into the company’s financial health.

Royal Bank of Canada is set to release its Q3 results on August 27 and has also partnered with Cohere to utilize its AI platform to automate tasks and improve operations.